Oblong (OBLG) 10-Q 13 May 21 2021 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2021	May 11, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2021
Document Transition Report	false
Entity File Number	001-35376
Entity Registrant Name	OBLONG, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	77-0312442
Entity Address, Address Line One	25587 Conifer Road
Entity Address, Address Line Two	Suite 105-231
Entity Address, City or Town	Conifer
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80433
City Area Code	303
Local Phone Number	640-3838
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	OBLG
Amendment Flag	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Central Index Key	0000746210
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		26,616,048
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Security Exchange Name	NASDAQ

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash	$ 3,964	$ 5,058
Current portion of restricted cash	61	158
Accounts receivable, net	1,779	3,166
Inventory	1,494	920
Prepaid expenses and other current assets	1,147	691
Total current assets	8,445	9,993
Property and equipment, net	430	573
Goodwill	7,367	7,367
Intangibles, net	9,543	10,140
Operating lease - right of use asset, net	773	903
Other assets	113	167
Total assets	26,671	29,143
Current liabilities:
Current portion of long-term debt	2,417	2,014
Accounts payable	1,079	313
Accrued expenses and other current liabilities	1,533	1,201
Current portion of deferred revenue	930	1,217
Current portion of operating lease liabilities	797	830
Total current liabilities	6,756	5,575
Long-term liabilities:
Long-term debt, net of current portion and net of discount	0	403
Operating lease liabilities, net of current portion	423	602
Deferred revenue, net of current portion	561	506
Total long-term liabilities	984	1,511
Total liabilities	7,740	7,086
Commitments and contingencies (see Note 13)
Stockholders’ equity:
Common stock, $.0001 par value; 150,000,000 shares authorized; 26,729,331 shares issued and 26,616,048 outstanding at March 31, 2021 and 7,861,912 shares issued and 7,748,629 outstanding at December 31, 2020	3	1
Treasury stock, 113,283 shares of common stock at March 31, 2021 and December 31, 2020	(181)	(181)
Additional paid-in capital	215,397	215,092
Accumulated deficit	(196,288)	(192,855)
Total stockholder's equity	18,931	22,057
Total liabilities and stockholders’ equity	26,671	29,143
Series A-2 Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Series D Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Series E Preferred Stock
Stockholders’ equity:
Preferred stock	$ 0	$ 0

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Preferred stock, convertible, shares authorized (in shares)	5,000,000
Preferred stock, convertible, shares issued (in shares)	0
Preferred stock, convertible, shares outstanding (in shares)	0	1,829,582
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	26,729,331	7,861,912
Common stock, shares outstanding (in shares)	26,616,048	7,748,629
Treasury stock, shares (in shares)	113,283	113,283
Series A-2 Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, stated value	$ 7,500	$ 7,500
Preferred stock, convertible, shares authorized (in shares)	7,500	7,500
Preferred stock, convertible, shares issued (in shares)	0	45
Preferred stock, convertible, shares outstanding (in shares)	0	45
Series D Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, stated value	$ 28.50	$ 28.50
Preferred stock, convertible, shares authorized (in shares)	1,750,000	1,750,000
Preferred stock, convertible, shares issued (in shares)	0	1,697,958
Preferred stock, convertible, shares outstanding (in shares)	0	1,697,958
Series E Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, stated value	$ 28.50	$ 28.50
Preferred stock, convertible, shares authorized (in shares)	175,000	175,000
Preferred stock, convertible, shares issued (in shares)	0	131,579
Preferred stock, convertible, shares outstanding (in shares)	0	131,579

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Revenue	$ 1,918	$ 5,328
Cost of revenue (exclusive of depreciation and amortization)	1,290	2,374
Gross profit	628	2,954
Operating expenses:
Research and development	692	1,327
Sales and marketing	527	1,220
General and administrative	2,067	2,028
Impairment charges	31	541
Depreciation and amortization	722	815
Total operating expenses	4,039	5,931
Loss from operations	(3,411)	(2,977)
Interest and other expense, net	5	154
Foreign exchange loss (gain)	17	(2)
Interest and other expense, net	22	152
Loss before income taxes	(3,433)	(3,129)
Income tax expense	0	0
Net loss	(3,433)	(3,129)
Preferred stock dividends	1	4
Undeclared dividends	366	0
Induced conversion of Series A-2 Preferred Stock	300	0
Net loss attributable to common stockholders	$ (4,100)	$ (3,133)
Net loss attributable to common stockholders per share:
Basic and diluted net loss per share (in dollars per share)	$ (0.23)	$ (0.60)
Weighted-average number of shares of common stock:
Basic and diluted (in shares)	17,756	5,204

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Series D and E Preferred Stock	Preferred StockSeries A-2 Preferred Stock	Preferred StockSeries C Preferred Stock	Preferred StockSeries D Preferred Stock	Preferred StockSeries E Preferred Stock	Common Stock	Common StockSeries A-2 Preferred Stock	Common StockSeries D and E Preferred Stock	Treasury Stock	Additional Paid-In Capital	Additional Paid-In CapitalSeries D and E Preferred Stock	Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2019			32	475	1,734,901	131,579	5,266,828			105,285
Beginning Balance at Dec. 31, 2019	$ 21,785		$ 0	$ 0	$ 0	$ 0	$ 1			$ (165)	$ 207,383		$ (185,434)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,129)												(3,129)
Stock-based compensation	32										32
Preferred stock conversion (in shares)				(150)			50,000
Issuance of preferred stock for accrued dividends (in shares)			13
Issuance of preferred stock for accrued dividends	98										98
Forfeited restricted stock (in shares)					14,441
Preferred stock dividends	(4)										(4)
Purchase of treasury stock	(7)									$ (7)
Ending Balance (in shares) at Mar. 31, 2020			45	325	1,720,460	131,579	5,316,828			105,285
Ending Balance at Mar. 31, 2020	18,775		$ 0	$ 0	$ 0	$ 0	$ 1			$ (172)	207,509		(188,563)
Beginning Balance (in shares) at Dec. 31, 2019			32	475	1,734,901	131,579	5,266,828			105,285
Beginning Balance at Dec. 31, 2019	$ 21,785		$ 0	$ 0	$ 0	$ 0	$ 1			$ (165)	207,383		(185,434)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation										$ (16)
Forfeited restricted stock (in shares)	0
Series D Preferred Stock exchanged for taxes (in shares)										(8,000)
Ending Balance (in shares) at Dec. 31, 2020			45		1,697,958	131,579	7,861,912			113,283
Ending Balance at Dec. 31, 2020	$ 22,057		$ 0		$ 0	$ 0	$ 1			$ (181)	215,092		(192,855)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,433)												(3,433)
Stock-based compensation	33										33
Preferred stock conversion (in shares)			(45)		(1,697,022)	(131,579)	18,846,411	84,292	18,762,119
Preferred stock conversion		$ 0							$ 2			$ (2)
Issuance of stock for services (in shares)							21,008
Issuance of stock for services	274										274
Forfeited restricted stock (in shares)					(81)
Series D Preferred Stock exchanged for taxes (in shares)					(855)
Ending Balance (in shares) at Mar. 31, 2021			0		0	0	26,729,331			113,283
Ending Balance at Mar. 31, 2021	$ 18,931		$ 0		$ 0	$ 0	$ 3			$ (181)	$ 215,397		$ (196,288)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020
Cash flows from operating activities:
Net loss	$ (3,433)	$ (3,129)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	722	815
Bad debt expense	240	13
Amortization of debt discount	0	34
Amortization of right of use asset	130	302
Loss on disposal of equipment	0	22
Common stock issued for services	274	0
Stock-based compensation	33	32
Loss on foreign currency remeasurement	4	0
Impairment charges - property and equipment	31	0
Impairment charges - goodwill	0	541	$ 541
Changes in operating assets and liabilities:
Accounts receivable	1,147	(1,679)
Inventory	(574)	377
Prepaid expenses and other current assets	(456)	(133)
Other assets	(7)	(59)
Accounts payable	766	274
Accrued expenses and other current liabilities	332	(398)
Deferred revenue	(232)	772
Lease liabilities	(212)	(320)
Net cash used in operating activities	(1,235)	(2,536)
Cash flows from investing activities:
Purchases of property and equipment	(17)	0
Net cash used in investing activities	(17)	0
Cash flows from financing activities:
Purchase of treasury stock	0	(7)
Net cash used in financing activities	0	(7)
Decrease in cash and restricted cash	(1,252)	(2,543)
Cash and restricted cash at beginning of period	5,277	4,602	4,602
Cash and restricted cash at end of period	4,025	2,059	5,277
Reconciliation of cash and restricted cash
Cash				$ 3,964	$ 5,058	$ 2,059
Current portion of restricted cash				61	158	0
Total cash and restricted cash	4,025	2,059	$ 4,602	4,025	$ 5,277	2,059
Cash paid during the period for interest	0	90
Non-cash investing and financing activities:
Issuance of preferred stock in exchange for accrued dividends	0	98
Accrued preferred stock dividends				$ 1		$ 4
Inducement to convert Series A-2 Preferred Stock to common	300	0
Common stock issued for services	$ 3	$ 0

Business Description and Signif

Business Description and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Business Description and Significant Accounting Policies	Note 1 - Business Description and Significant Accounting Policies Business Description Oblong, Inc. (“Oblong” or “we” or “us” or the “Company”) was formed as a Delaware corporation in May 2000 and is a provider of patented multi-stream collaboration technologies and managed services for video collaboration and network applications. Prior to March 6, 2020, Oblong, Inc. was named Glowpoint, Inc. (“Glowpoint”). On March 6, 2020, Glowpoint changed its name to Oblong, Inc. Basis of Presentation The Company's fiscal year ends on December 31, of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2020. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The December 31, 2020 year-end condensed consolidated balance sheet data in this document was derived from audited consolidated financial statements. These condensed consolidated financial statements and notes included in this quarterly report on Form 10-Q does not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2020 and notes thereto included in the Company's fiscal 2020 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 30, 2021 (the “2020 10-K”). The results of operations and cash flows for the interim periods included in these condensed consolidated financial statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. Principles of Consolidation The condensed consolidated financial statements include the accounts of Oblong and our 100%-owned subsidiaries, (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, (ii) Oblong Industries, and (iii) the following subsidiaries of Oblong Industries: Oblong Industries Europe, S.L. and Oblong Europe Limited. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries. Segments The Company currently operates in two segments: 1) the Oblong (formerly Glowpoint) business, which includes managed services for video collaboration and network applications, and 2) the Oblong Industries business, which includes products and services for visual collaboration technologies. See Note 11 - Segment Reporting for further discussion. Use of Estimates Preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowance for doubtful accounts, the estimated lives and recoverability of property and equipment, and intangible assets, the inputs used in the valuation of goodwill and intangible assets in connection with our impairment tests, and the inputs used in the fair value of equity based awards as well as the values ascribed to assets acquired and liabilities assumed in the business combination. Significant Accounting Policies The significant accounting policies used in preparation of these condensed consolidated financial statements are disclosed in our 2020 10-K, and there have been no changes to the Company’s significant accounting policies during the three months ended March 31, 2021. Property and Equipment Property and equipment are stated at cost and are depreciated over the estimated useful lives of the related assets, which range from three Recently Issued Accounting Pronouncements In June 2016 the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13 as amended, “Financial Instruments - Credit Losses (Topic 326).” Topic 326 introduces an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g. accounts receivable, loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses should consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. Topic 326 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact the new guidance will have on its consolidated financial statements.

Liquidity and Going Concern Unc

Liquidity and Going Concern Uncertainty	3 Months Ended
	Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liquidity and Going Concern Uncertainty	Note 2 - Liquidity and Going Concern Uncertainty As of March 31, 2021, we had $3,964,000 of unrestricted cash, obligations of $2,417,000 under the Paycheck Protection Program loan (the “PPP Loan”), and working capital of $1,689,000. For the three months ended March 31, 2021, we incurred a net loss of $3,433,000 and used $1,235,000 of net cash in operating activities. See further discussion of the PPP Loan in Note 6 - Debt . Our capital requirements in the future will continue to depend on numerous factors, including the timing and amount of revenue for the Company, customer renewal rates and the timing of collection of outstanding accounts receivable, in each case particularly as it relates to the Company’s major customers, the expense to deliver services, expense for sales and marketing, expense for research and development, capital expenditures, the cost involved in protecting intellectual property rights, the amount of forgiveness of the PPP Loan, if any, and the debt service obligations under the PPP Loan. While our acquisition of Oblong Industries provides additional revenues to the Company, the cost to further develop and commercialize Oblong Industries’ product offerings is expected to exceed its revenues for the foreseeable future. We expect to continue to invest in product development and sales and marketing expenses with the goal of growing the Company’s revenue in the future. The Company believes that, based on the Company’s current projection of revenue, expenses, capital expenditures, debt service obligations, and cash flows, it will not have sufficient resources to fund its operations for the next twelve months following the filing of this Report. We believe additional capital will be required to fund operations and provide growth capital including investments in technology, product development and sales and marketing. To access capital to fund operations or provide growth capital, we will need to raise capital in one or more debt and/or equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company. The factors discussed above raise substantial doubt as to our ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from these uncertainties. See Note 12 - Commitments and Contingencies to our condensed consolidated financial statements for discussion regarding certain additional factors that could impact the Company’s liquidity in the future.

Goodwill

Goodwill	3 Months Ended
	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Note 3 - Goodwill As of March 31, 2021 and December 31, 2020, goodwill was $7,367,000, comprised of amounts recorded in connection with the October 1, 2019 Acquisition of Oblong Industries. We test goodwill for impairment on an annual basis on September 30 of each year, or more frequently if events occur or circumstances change indicating that the fair value of the goodwill may be below its carrying amount. The Company operates two reporting segments, Oblong (formerly Glowpoint) and Oblong Industries. In March 31, 2020, we considered the novel Coronavirus (COVID-19) pandemic and resulting declines in certain of the Company’s revenue to be a triggering event for an interim goodwill impairment test for both reporting units. To determine the fair value of each reporting unit, as of March 31, 2020 for the goodwill impairment tests, we used a weighted average of the discounted cash flow method and a market-based method (comparing the Company’s equity and analyzing multiples of revenue for comparable companies). For the Oblong Industries reporting unit, the fair value of the reporting unit exceeded its carrying amount, therefore no impairment charge was required. For the Oblong (formerly Glowpoint) reporting unit, we recorded an impairment charge on goodwill of $541,000 for the three months ended March 31, 2020 as the carrying amount of the reporting unit exceeded its fair value on the test date. This charge is recognized as an impairment charge on our condensed consolidated Statements of Operations. There were no such triggering events during the three months ended March 31, 2021, therefore, no impairment charges were recorded. The activity in goodwill during the three months ended March 31, 2021 and the year ended December 31, 2020 is shown in the following table ($ in thousands): Goodwill Oblong (formerly Glowpoint) Oblong Industries Total Balance December 31, 2019 $ 541 $ 7,367 $ 7,908 Impairment charges (541) — (541) Balance December 31, 2020 — 7,367 7,367 Balance March 31, 2021 $ — $ 7,367 $ 7,367 In the event we experience future declines in our revenue, cash flows and/or stock price, this may give rise to a triggering event that may require the Company to record additional impairment charges on goodwill in the future.

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 4 - Intangible Assets The following table presents the components of net intangible assets (in thousands): As of March 31, 2021 As of December 31, 2020 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Oblong (formerly Glowpoint) Affiliate network $ 994 $ (752) $ 242 $ 994 $ (735) $ 259 Oblong Industries Developed technology $ 10,060 $ (3,024) $ 7,036 $ 10,060 $ (2,520) $ 7,540 Trade names 2,410 (362) 2,048 2,410 (302) 2,108 Distributor relationships 310 (93) 217 310 (77) 233 Subtotal 12,780 (3,479) 9,301 12,780 (2,899) 9,881 Total $ 13,774 $ (4,231) $ 9,543 $ 13,774 $ (3,634) $ 10,140 At each reporting period, we determine if there was a triggering event that may result in an impairment of our intangible assets. During the three months ended March 31, 2020, we considered the novel Coronavirus (COVID-19) pandemic and resulting declines in certain of the Company’s revenue to be a triggering event for an interim impairment test of intangible assets for both reporting units. Based on the corresponding recoverability test, we determined that no impairment charges were required for the three months ended March 31, 2020. During the three months ended March 31, 2021, we considered the decline in revenue for Oblong Industries to be a triggering event for an interim impairment test of intangible assets for this reporting unit. Based on the corresponding recoverability test of Oblong Industries’ intangible assets, we determined no impairment changes were required for the three months ended March 31, 2021. Intangible assets with finite lives are amortized using the straight-line method over the estimated economic lives of the assets, which range from five years to twelve years in accordance with ASC Topic 350. The weighted average lives for the components of intangible assets are as follows: Oblong (formerly Glowpoint) Affiliate network 12 years Oblong Industries Developed technology 5 years Trade names 10 years Distributor relationships 5 years Related amortization expense was $597,000 and $611,000 for the three months ended March 31, 2021 and 2020, respectively. Amortization expense for each of the next five succeeding years will be as follows (in thousands): Remainder of 2021 $ 1,791 2022 2,386 2023 2,378 2024 1,843 2025 241 Thereafter 904 Total $ 9,543

Accrued Expenses and Other Liab

Accrued Expenses and Other Liabilities	3 Months Ended
	Mar. 31, 2021
Other Liabilities Disclosure [Abstract]
Accrued Expenses and Other Liabilities	Note 5 - Accrued Expenses and Other Liabilities Accrued expenses and other liabilities consisted of the following (in thousands): March 31, December 31, 2021 2020 Accrued compensation costs $ 569 $ 411 Accrued professional fees 255 236 Accrued taxes and regulatory fees 156 137 Customer deposits 136 127 Other accrued expenses and liabilities 417 286 Accrued dividends on Series A-2 Preferred Stock — 4 Accrued expenses and other liabilities $ 1,533 $ 1,201

Debt

Debt	3 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
Debt	Note 6 - Debt Debt consisted of the following (in thousands): March 31, December 31, 2021 2020 PPP Loan Principal $ 2,417 $ 2,417 Less: current maturities 2,417 2,014 Long-term obligations, net of current maturities $ — $ 403 Paycheck Protection Program Loan On April 10, 2020 (the “Origination Date”), the Company received $2,417,000 in aggregate loan proceeds (the “PPP Loan”) from MidFirst Bank (the “Lender”) pursuant to the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The PPP Loan is evidenced by a Promissory Note (the “Note”), dated April 10, 2020, by and between the Company and the Lender. Subject to the terms of the Note, the PPP Loan bears interest at a fixed rate of one percent (1.0%) per annum. Payments of principal and interest are deferred for the first six months following the Origination Date. Following the deferral period, the Company will be required to make payments of principal plus interest accrued under the PPP Loan to the Lender in 18 monthly installments based upon an amortization schedule to be determined by the Lender based on the principal balance of the Note outstanding following the deferral period and taking into consideration any portion of the PPP Loan that is forgiven prior to that time. The PPP Loan is unsecured and guaranteed by the U.S. Small Business Administration. The Paycheck Protection Program provides for forgiveness of up to the full amount borrowed as long as the Company uses the loan proceeds during the 24-week period following disbursement for eligible purposes as described in the CARES Act and related guidance. Under the CARES Act, loan forgiveness is generally available for the sum of documented payroll costs, covered rent payments, covered mortgage interest and covered utilities during the 24-week period. The Company used the majority of the proceeds from the PPP Loan to pay expenses during the applicable period that the Company believes were for eligible purposes; certain reductions in Company payroll costs during this period may reduce the amount of the Note eligible for forgiveness. In May 2021, the Company submitted an application to the Lender for forgiveness of the PPP Loan and the application is currently under review by the Lender. There is no guarantee that the Company will receive forgiveness for any fixed amount of any PPP Loan principal received by the Company. Under the revised rules for the PPP Loan program, the Company will not have to begin principal and interest payments before the date on which the SBA remits the loan forgiveness amount to the Lender (or notifies the Lender that no loan forgiveness is allowed). Following the decision on forgiveness, the Company will be required to pay the Lender equal monthly payments of principal and interest based on the principal amount outstanding on the PPP Loan, plus interest outstanding at the end of the deferment period, and taking into account any reductions in the principal amount due to forgiveness, if any. Interest accrued during the deferment period will be capitalized as principal.

Capital Stock

Capital Stock	3 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Capital Stock	Note 7 - Capital Stock Common Stock On February 1, 2021, the Company, acting pursuant to authorization from its Board of Directors, determined to voluntarily withdraw the listing of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), from the NYSE American Stock Exchange (the “NYSE American”) and transfer such listing to The Nasdaq Capital Market (“Nasdaq”). The Company’s listing and trading of its Common Stock on the NYSE American ended at market close on February 11, 2021, and trading began on Nasdaq at market open on February 12, 2021, and is continuing to trade under the ticker symbol “OBLG”. As of March 31, 2021, we had 150,000,000 shares of our Common Stock authorized, with 26,729,331 and 26,616,048 shares of issued and outstanding, respectively. During the three months ended March 31, 2021 and 2020, 18,846,411 and 50,000 shares of the Company’s Common stock were issued in relation to preferred stock conversions, respectively. Issuance for Professional Service Fees On December 10, 2020, the Company issued 50,000 shares of Common Stock as payment for services, with a fair value equal to $348,000, related to a financial advisory agreement entered into on December 1, 2020. On January 21, 2021, the Company issued 21,008 shares of Common Stock as payment for services, with a fair value equal to $100,000, related to a financial advisory agreement entered into on January 15, 2021. During the three months ended March 31, 2021, the Company expensed $274,000 as professional service fees included as a component of general and administrative expense in the accompanying condensed consolidated Statements of Operations. Warrants On October 21, 2020, the Company issued warrants to purchase up to 521,500 shares of Common Stock pursuant to a securities purchase agreement with certain accredited investors. The Warrants have a term of 2 years, are initially exercisable at $4.08 per share and are subject to cashless exercise if, at the time of exercise, the Warrant Shares are not subject to an effective resale registration statement. The Warrants are also subject to adjustment in the event of (i) stock splits and dividends, (ii) subsequent rights offerings, (iii) pro-rata distributions, and (iv) certain fundamental transactions, including but not limited to the sale of the Company, business combinations, and reorganizations. The Warrants do not have any price protection or price reset provisions with respect to future issuances of securities. The fair value of the Warrants was recorded to additional paid-in capital during the year ended December 31, 2020 and was determined to be $1,334,087 using the Black-Scholes model. As of March 31, 2021, no warrants had been exercised. On December 6, 2020, the Company issued warrants to purchase up to 625,000 shares of Common Stock pursuant to a securities purchase agreement with certain accredited investors. The Warrants have a term of 2 years, are initially exercisable at $5.49 per share and are subject to cashless exercise if, at the time of exercise, the Warrant Shares are not subject to an effective resale registration statement. The Warrants are also subject to adjustment in the event of (i) stock splits and dividends, (ii) subsequent rights offerings, (iii) pro-rata distributions, and (iv) certain fundamental transactions, including but not limited to the sale of the Company, business combinations, and reorganizations. The Warrants do not have any price protection or price reset provisions with respect to future issuances of securities. The fair value of the Warrants was recorded to additional paid-in capital during the year ended December 31, 2020 and was determined to be $2,635,425 using the Black-Scholes model. As of March 31, 2021, no warrants had been exercised. Warrant activity for the year ended December 31, 2020 is presented below. There was no warrant activity for the three months ended March 31, 2021. Outstanding Number of Warrants (in thousands) Weighted Average Exercise Price Warrants outstanding and exercisable, December 31, 2019 72 0.01 Granted 1,147 4.85 Exercised (72) 0.01 Warrants outstanding and exercisable, December 31, 2020 1,147 $ 4.85 Warrants outstanding and exercisable, March 31, 2021 1,147 $ 4.85 Treasury Shares The Company maintains Treasury Stock for the Common Stock shares bought back by the Company when withholding shares to cover taxes on Stock Compensation transactions. The following table shows the activity for Treasury Stock during the year ended December 31, 2020 (in thousands). There were no treasury stock transactions during the three months ended March 31, 2021. Shares Value Treasury Shares as of December 31, 2019 105 $ (165) Purchases to cover stock compensation taxes 8 $ (16) Treasury Shares as of December 31, 2020 113 $ (181) Treasury Shares as of March 31, 2021 113 $ (181)

Preferred Stock

Preferred Stock	3 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Preferred Stock	Note 8 - Preferred Stock Our Certificate of Incorporation authorizes the issuance of up to 5,000,000 shares of preferred stock. As of March 31, 2021, we had 1,941,250 designated shares of preferred stock and no shares of preferred stock issued and outstanding. As of December 31, 2020, we had 1,829,582 shares of preferred stock outstanding. Series A-2 Preferred Stock As of December 31, 2020, there were 45 shares of Series A-2 Preferred Stock issued and outstanding. Each share of Series A-2 Preferred Stock had a stated value of $7,500 per share (the “A-2 Stated Value”), a liquidation preference equal to the Series A-2 Stated Value, and was convertible at the holder’s election into common stock at a conversion price per share of $16.11. Therefore, each share of Series A-2 Preferred Stock was convertible into 466 shares of common stock, for an aggregate of 20,954 shares of common stock. The Series A-2 Preferred Stock was senior to all outstanding classes of the Company’s equity and was entitled to cumulative dividends at a rate of 5.0% per annum. As of December 31, 2020, the Company had recorded $4,000 in accrued dividends on the accompanying condensed consolidated Balance Sheets related to the Series A-2 Preferred Stock outstanding. During the three months ended March 31, 2021, an additional $1,000 dividend expense was recorded. On January 28, 2021, the Company entered into an agreement with the holder of the Series A-2 Preferred Stock to convert the Stated Value of all outstanding shares of the Series A-2 Preferred Stock, 45 shares, into 84,292 shares of the Company’s common stock, at a negotiated conversion price of $4.00 per share, after taking into consideration accrued and unpaid dividends. As of March 31, 2021, there are no shares of Series A-2 Preferred Stock outstanding. The incremental cost of inducing the conversion was approximately $300,000 and was treated similarly to a preferred dividend, increasing the net loss attributable to common stockholders. Series D and E Preferred Stock In connection with the Oblong Industries acquisition, on October 1, 2019 (the “Closing Date”), the Company issued an aggregate of 1,686,659 shares of Series D Preferred Stock and an aggregate of 49,967 restricted shares of Series D Preferred Stock (“Restricted Series D Preferred Stock”), the latter of which were subject to vesting over a two-year period following the Closing Date of the acquisition. Pursuant to the terms of the Series D Certificate of Designations, each share of Series D Preferred Stock was entitled to receive an annual dividend equal to 6.0% of its then-existing Accrued Value per annum, commencing on the first anniversary of the issuance of the Series D Preferred Stock (or October 1, 2020). Prior to the first anniversary of the issuance of the Series D Preferred Stock no dividends accrued on such stock. Dividends were cumulative and accrued daily in arrears. The Company’s Board of Directors did not declare any applicable dividend payment in cash, therefore, the Accrued Value of the Series D Preferred Stock was increased by the amount of such dividend payment. During the year ended December 31, 2020, 28,618 shares of Restricted Series D Preferred Stock were forfeited and 8,325 shares of Series D Preferred Stock were surrendered to cover the taxes on vesting shares. During the three months ended March 31, 2021, 81 shares of Restricted Series D Preferred Stock were forfeited and 855 shares of Series D Preferred Stock were surrendered to cover the taxes on vesting shares. On October 1, 2019, Oblong entered into a Series E Preferred Stock Purchase Agreement relating to the offer and sale by the Company of up to 131,579 shares of its Series E Preferred Stock at a price of $28.50 per share. The Company sold a total of 131,579 shares of Series E Preferred Stock for net proceeds of approximately $3,750,000. The 131,579 shares of Series E Preferred Stock had an aggregate Accrued Value of $3,750,000 and upon their conversion would convert at a conversion price of $2.85 per share into 1,315,790 common shares. Pursuant to the terms of the Series E Certificate of Designations, each share of Series E Preferred Stock was entitled to receive an annual dividend equal to 6.0% of its then-existing Accrued Value per annum, commencing on the first anniversary of the issuance of the Series E Preferred Stock (or October 1, 2019 or December 18, 2019, as applicable). Prior to the first anniversary of the issuance of the Series E Preferred Stock no dividends accrued on such stock. Dividends were cumulative and accrue daily in arrears. The Company’s Board of Directors did not declare any applicable dividend payment in cash; therefore, the Accrued Value of the Series E Preferred Stock was increased by the amount of such dividend payment. The terms of the Company’s Series D and Series E Preferred Stock provided that such shares were automatically convertible into a number of shares of the Company’s Common Stock equal to the accrued value of the preferred shares (initially $28.50), plus any accrued dividends thereon, divided by the conversion price (initially $2.85 per share, subject to specified adjustments) upon the completion of both (i) approval of such conversion by the Company’s stockholders entitled to vote thereon (which occurred on December 19, 2019); and (ii) the receipt of all required authorizations and approval of a new listing application for the Company following the Company’s October 2019 acquisition of Oblong Industries, Inc. from the NYSE American or any such other exchange upon which the Company’s securities are then listed for trading. The Company determined that this conversion condition was completed in its entirety, and the Series D and E Preferred Stock automatically converted to shares of Common Stock pursuant to their terms, effective upon the commencement of trading of the Company’s Common Stock on Nasdaq as described above, on February 12, 2021. As of the date of conversion, the Company had 1,697,022 shares of Series D Preferred Stock and 131,579 shares of Series E Preferred Stock outstanding, respectively. The outstanding shares of Series D and Series E Preferred stock were converted into 17,416,939 and 1,345,180 shares of Common Stock, respectively, after taking into consideration all accrued and unpaid dividends. Following the conversion of the Series A-2, Series D, and Series E Preferred Stock, the Company no longer has shares of Preferred Stock issued and outstanding.

Stock Based Compensation

Stock Based Compensation	3 Months Ended
	Mar. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock Based Compensation	Note 9 - Stock Based Compensation 2019 Equity Incentive Plan On December 19, 2019, the Oblong, Inc. 2019 Equity Incentive Plan (the “2019 Plan”) was approved by the Company’s stockholders at the Company’s 2019 Annual Meeting of Stockholders. The 2019 Plan is an omnibus equity incentive plan pursuant to which the Company may grant equity and cash incentive awards to certain key service providers of the Company and its subsidiaries. The 2019 Plan replaced the Glowpoint, Inc. 2014 Equity Incentive Plan and the 2007 Stock Incentive Plan (the “Prior Plans”). Following approval of the 2019 Plan, the Company terminated the Prior Plans and may no longer make grants under the Prior Plans; however, any outstanding equity awards granted under the Prior Plans will continue to be governed by the terms of the Prior Plans. Stock Options For the three months ended March 31, 2021 and the year ended December 31, 2020, no stock options were granted. A summary of stock options expired and forfeited under our plans and options outstanding as of, and changes made during, the three months ended March 31, 2021 and the year ended December 31, 2020 is presented below: Outstanding and Exercisable Number of Options Weighted Average Exercise Price Options outstanding and exercisable, December 31, 2019 215,345 $ 12.27 Expired (107,845) 4.92 Forfeited — — Options outstanding and exercisable, December 31, 2020 107,500 19.64 Options outstanding and exercisable, March 31, 2021 107,500 $ 19.64 Additional information as of March 31, 2021 is as follows: Outstanding and Exercisable Range of price Number Weighted Weighted $0.00 – $10.00 2,500 2.20 $ 9.00 $10.01 – $20.00 97,500 1.81 19.32 $20.01 – $30.00 2,500 1.19 21.80 $30.01 – $40.00 5,000 0.96 30.20 107,500 1.76 $ 19.64 The intrinsic value of vested options, unvested options and exercised options were not significant for all periods presented. There was no stock compensation expense related to stock options for the three months ended March 31, 2021 and 2020, and no remaining unrecognized stock-based compensation expense for options as of March 31, 2021 as all options were vested. Restricted Stock Awards As of March 31, 2021 and 2020, there were 627 unvested restricted stock awards outstanding, with a weighted average grant date price of $15.80. The awards were issued in 2014 and vest over the lesser of ten years, a change in control, or separation from the company. Due to the variability of the vesting, the expense was amortized over an average service period of five years; therefore, there is no unrecognized stock-based compensation expense for restricted stock awards for the three months ended March 31, 2021 and 2020. Restricted Stock Units As of March 31, 2021 and 2020, there were zero and 23,334 unvested restricted stock units outstanding, respectively. The 23,334 units outstanding at March 31, 2020 had a weighted average grant price of 2.20. As of March 31, 2021, 28,904 vested RSU’s remain outstanding as shares of common stock have not yet been delivered for these units in accordance with the terms of the RSU’s. Stock compensation expense for the three months ended March 31, 2021 and 2020 was zero and $6,000, respectively, and was included in general and administrative expense. There was no remaining unrecognized stock-based compensation expense for restricted stock units at March 31, 2021. Restricted Series D Preferred Stock In connection with the acquisition of Oblong Industries in 2019, all options to purchase shares of Oblong Industries’ common stock held by existing employees of Oblong Industries were canceled and exchanged for an aggregate of 49,967 shares of Restricted Series D Preferred Stock, which were subject to vesting over a two-year period following the Closing Date. This vesting period and compensation expense were accelerated, in February 2021, when the Restricted Series D shares were converted to shares of Common Stock. Refer to Note 8 - Preferred Stock for discussion on the conversion of the Series D Restricted Preferred Stock. Stock-based compensation expense relating to Restricted Series D Preferred Stock is allocated as follows (in thousands): Three Months Ended March 31, 2021 2020 Research and development $ 17 $ 47 Sales, general and administrative $ 16 $ 111 $ 33 $ 158

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Mar. 31, 2021
Earnings Per Share [Abstract]
Net Loss Per Share	Note 10 - Net Loss Per Share Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does not include any potentially dilutive securities or unvested restricted stock. Unvested restricted stock, although classified as issued and outstanding at March 31, 2021 and 2020, is considered contingently returnable until the restrictions lapse and will not be included in the basic net loss per share calculation until the shares are vested. Unvested restricted stock does not contain non-forfeitable rights to dividends and dividend equivalents. Unvested RSUs are not included in calculations of basic net loss per share, as they are not considered issued and outstanding at time of grant. Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, RSUs, and unvested restricted stock, to the extent they are dilutive. For the three months ended March 31, 2021 and 2020, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (due to the net loss). The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data): Three Months Ended March 31, 2021 2020 Numerator: Net loss $ (3,433) $ (3,129) Less: preferred stock dividends (1) (4) Less: undeclared dividends (366) — Less: loss on induced conversion of Series A-2 Preferred Stock (300) — Net loss attributable to common stockholders $ (4,100) $ (3,133) Denominator: Weighted-average number of shares of common stock for diluted net loss per share 17,756 5,204 Basic and diluted net loss per share $ (0.23) $ (0.60) The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss): Three Months Ended March 31, 2021 2020 Unvested restricted stock units — 23,334 Outstanding stock options 107,500 215,345 Unvested restricted stock awards 627 627 Shares of common stock issuable upon conversion of Series A-2 preferred stock — 10,978 Shares of common stock issuable upon conversion of Series C preferred stock — 108,333 Shares of common stock issuable upon conversion of Series D preferred stock — 17,020,460 Shares of common stock issuable upon conversion of Series E preferred stock — 1,315,790 Warrants 1,146,500 72,394

Segment Reporting

Segment Reporting	3 Months Ended
	Mar. 31, 2021
Segment Reporting [Abstract]
Segment Reporting	Note 11 - Segment Reporting The Company currently operates in two segments: (1) the Oblong (formerly Glowpoint) business, which mainly consists of managed services for video collaboration and network applications; and (2) the Oblong Industries business, which consists of products and services for visual collaboration technologies. Certain information concerning the Company’s segments for the three months ended March 31, 2021 is presented in the following tables (in thousands): Three Months Ended March 31, 2021 Oblong (formerly Glowpoint) Oblong Industries Corporate Total Revenue $ 1,195 $ 723 $ — $ 1,918 Cost of revenues 833 457 — 1,290 Gross profit $ 362 $ 266 $ — $ 628 Gross profit % 30 % 37 % 33 % Allocated operating expenses $ 110 $ 1,831 $ — $ 1,941 Unallocated operating expenses $ — $ — 2,098 2,098 Total operating expenses $ 110 $ 1,831 $ 2,098 $ 4,039 Income (loss) from operations $ 252 $ (1,565) $ (2,098) $ (3,411) Interest and other expense, net 5 17 $ — 22 Net income (loss) before tax $ 247 $ (1,582) $ (2,098) $ (3,433) Income Tax $ — $ — $ — $ — Net income (loss) $ 247 $ (1,582) $ (2,098) $ (3,433) Three Months Ended March 31, 2020 Oblong (formerly Glowpoint) Oblong Industries Corporate Total Revenue $ 2,045 $ 3,283 $ — $ 5,328 Cost of revenues 1,156 1,218 — 2,374 Gross profit $ 889 $ 2,065 $ — $ 2,954 Gross profit % 43 % 63 % 55 % Allocated operating expenses $ 1,290 $ 2,073 $ — $ 3,363 Unallocated operating expenses — — 2,568 2,568 Total operating expenses $ 1,290 $ 2,073 $ 2,568 $ 5,931 Loss from operations $ (401) $ (8) $ (2,568) $ (2,977) Interest and other expense, net — — 152 152 Loss before income taxes $ (401) $ (8) $ (2,720) $ (3,129) Income tax expense $ — $ — $ — $ — Net loss $ (401) $ (8) $ (2,720) $ (3,129) Unallocated operating expenses include costs for the three months ended March 31, 2021 and 2020 that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees and other similar corporate expenses. For the three months ended March 31, 2021 and 2020, there was no material revenue attributable to any individual foreign country. Approximately 1% of foreign revenue is billed in foreign currency and foreign currency gains and losses are not material. Revenue by geographic area is allocated as follows (in thousands): Three Months Ended March 31, 2021 2020 Domestic $ 1,015 $ 3,602 Foreign 903 1,726 $ 1,918 $ 5,328 Disaggregated information for the Company’s revenue has been recognized in the accompanying condensed consolidated statements of operations and is presented below according to contract type (in thousands): Three Months Ended March 31, 2021 % of Revenue 2020 % of Revenue Revenue: Oblong (formerly Glowpoint) Video collaboration services $ 291 15 % $ 1,046 20 % Network services 881 46 % 925 17 % Professional and other services 23 1 % 74 1 % Total Oblong revenue $ 1,195 62 % $ 2,045 38 % Revenue: Oblong Industries Visual collaboration product offerings $ 693 36 % 2,322 44 % Professional services — — % 669 13 % Licensing 30 2 % 292 5 % Total Oblong Industries revenue $ 723 38 % 3,283 62 % Total revenue $ 1,918 100 % $ 5,328 100 % The Company considers a significant customer to be one that comprises more than 10% of the Company’s consolidated revenues or accounts receivable. The loss of or a reduction in sales or anticipated sales to our most significant or several of our smaller customers could have a material adverse effect on our business, financial condition and results of operations. Concentration of revenues was as follows: Three Months Ended March 31, 2021 2020 Segment % of Revenue % of Revenue Customer A Oblong (formerly Glowpoint) 36 % 11 % Customer B Oblong Industries — % 22 % Customer C Oblong (formerly Glowpoint) 10 % * Concentration of accounts receivable was as follows: As of March 31, 2021 2021 2020 Segment % of Accounts Receivable % of Accounts Receivable Customer A Oblong Industries 36 % — % Customer B Oblong (formerly Glowpoint) 14 % * Customer C Oblong Industries — % 42 % Customer D Oblong Industries * 11 % * The amount did not exceed 10% of the Company’s consolidated total accounts receivable.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 12 - Commitments and Contingencies Operating Leases We currently lease three facilities in Los Angeles, California, one facility in Boston, Massachusetts, one facility in Dallas, Texas, and one facility in Munich Germany, all providing office space. We also lease space in City of Industry, California, providing warehouse space. These leases expire between 2022 and 2023. During 2020, we exited leases in Herndon, Virginia; Atlanta, Georgia; Houston, Texas; London, England, and a warehouse space in Los Angeles, California. In February 2021, we exited an office space lease in Los Altos, California, when the Company elected to not renew the lease. Although subject to COVID restrictions, we currently occupy two of the facilities in Los Angeles and the warehouse space in City of Industry; we have subleases in place for the third Los Angeles property, the Dallas property, and the Boston property. The Munich property is not in use and the Company is considering its options with this lease. Lease expenses, net of common charges and sublet proceeds, for the years ended March 31, 2021 and 2020 were $267,000 and $316,000, respectively. The Company primarily leases facilities for office and data center space under non-cancellable operating leases for its U.S. and international locations that expire at various dates through 2023. For leases with a term greater than 12 months, the Company recognizes a right-of-use asset and a lease liability based on the present value of lease payments over the lease term. Variable lease payments are not included in the lease payments to measure the lease liability and are expensed as incurred. The Company’s leases have remaining terms of one As the Company's leases do not provide a readily determinable implicit rate, the Company uses the incremental borrowing rate at lease commencement, which was determined using a portfolio approach, based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. Operating lease expense is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recognized on the balance sheet and the expense for these short-term leases is recognized on a straight-line basis over the lease term. Common area maintenance fees (or CAMs) and other charges related to these leases continue to be expensed as incurred. The following provides balance sheet information related to leases as of March 31, 2021 (in thousands): March 31, 2021 Assets Operating lease, right-of-use asset, net $ 773 Liabilities Current portion of operating lease liabilities $ 797 Operating lease liabilities, net of current portion 423 Total operating lease liabilities $ 1,220 The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands): Remaining Lease Payments Remainder of 2021 $ 661 2022 508 2023 116 Total lease payments $ 1,285 Effect of discounting (65) Total lease liability $ 1,220 COVID-19 On March 11, 2020, the World Health Organization announced that infections of the novel Coronavirus (COVID-19) had become pandemic, and on March 13, the U.S. President announced a National Emergency relating to the disease. There is a possibility of continued widespread infection in the United States and abroad, with the potential for catastrophic impact. National, state and local authorities have required or recommended social distancing and imposed or are considering quarantine and isolation measures on large portions of the population, including mandatory business closures. These measures, while intended to protect human life, are expected to have serious adverse impacts on domestic and foreign economies of uncertain severity and duration. Some economists are predicting the United States may soon enter a recession. The sweeping nature of the coronavirus pandemic makes it extremely difficult to predict how the Company’s business and operations will be affected in the longer run. The COVID-19 pandemic has materially affected our revenue and results of operations for the three months ended March 31, 2021, as we experienced delayed orders in our distribution channels as a direct result of customer implementation schedules shifting due to the ongoing COVID-19 pandemic. The extent to which the coronavirus impacts our future results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others. Moreover, the coronavirus outbreak has begun to have indeterminable adverse effects on general commercial activity and the world economy, and our business and results of operations could be adversely affected to the extent that this coronavirus or any other epidemic harms the global economy generally and/or the markets in which we operate specifically. Any of the foregoing factors, or other cascading effects of the coronavirus pandemic that are not currently foreseeable, could materially increase our costs, negatively impact our revenues and damage the Company’s results of operations and its liquidity position, possibly to a significant degree. The duration of any such impacts cannot be predicted. Uncertainties resulting from COVID-19 may result in additional customers delaying budget expenditures or re-allocating resources, which would result in a decrease in orders from these customers. Any such decrease in orders from these customers could cause a material adverse effect on our revenues and financial results and our ability to generate positive cash flows.

Business Description and Sign_2

Business Description and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company's fiscal year ends on December 31, of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2020. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. The December 31, 2020 year-end condensed consolidated balance sheet data in this document was derived from audited consolidated financial statements. These condensed consolidated financial statements and notes included in this quarterly report on Form 10-Q does not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2020 and notes thereto included in the Company's fiscal 2020 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 30, 2021 (the “2020 10-K”).
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of Oblong and our 100%-owned subsidiaries, (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, (ii) Oblong Industries, and (iii) the following subsidiaries of Oblong Industries: Oblong Industries Europe, S.L. and Oblong Europe Limited. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries.
Segments	Segments The Company currently operates in two segments: 1) the Oblong (formerly Glowpoint) business, which includes managed services for video collaboration and network applications, and 2) the Oblong Industries business, which includes products and services for visual collaboration technologies. See Note 11 - Segment Reporting for further discussion.
Use of Estimates	Use of Estimates Preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include
Property and Equipment	Property and Equipment Property and equipment are stated at cost and are depreciated over the estimated useful lives of the related assets, which range from three
Recently Adopted Accounting Standards and Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In June 2016 the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13 as amended, “Financial Instruments - Credit Losses (Topic 326).” Topic 326 introduces an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g. accounts receivable, loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses should consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. Topic 326 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact the new guidance will have on its consolidated financial statements.

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The activity in goodwill during the three months ended March 31, 2021 and the year ended December 31, 2020 is shown in the following table ($ in thousands): Goodwill Oblong (formerly Glowpoint) Oblong Industries Total Balance December 31, 2019 $ 541 $ 7,367 $ 7,908 Impairment charges (541) — (541) Balance December 31, 2020 — 7,367 7,367 Balance March 31, 2021 $ — $ 7,367 $ 7,367

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The following table presents the components of net intangible assets (in thousands): As of March 31, 2021 As of December 31, 2020 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Oblong (formerly Glowpoint) Affiliate network $ 994 $ (752) $ 242 $ 994 $ (735) $ 259 Oblong Industries Developed technology $ 10,060 $ (3,024) $ 7,036 $ 10,060 $ (2,520) $ 7,540 Trade names 2,410 (362) 2,048 2,410 (302) 2,108 Distributor relationships 310 (93) 217 310 (77) 233 Subtotal 12,780 (3,479) 9,301 12,780 (2,899) 9,881 Total $ 13,774 $ (4,231) $ 9,543 $ 13,774 $ (3,634) $ 10,140 The weighted average lives for the components of intangible assets are as follows: Oblong (formerly Glowpoint) Affiliate network 12 years Oblong Industries Developed technology 5 years Trade names 10 years Distributor relationships 5 years
Schedule of Future Amortization Expense	Amortization expense for each of the next five succeeding years will be as follows (in thousands): Remainder of 2021 $ 1,791 2022 2,386 2023 2,378 2024 1,843 2025 241 Thereafter 904 Total $ 9,543

Accrued Expenses and Other Li_2

Accrued Expenses and Other Liabilities (Tables)	3 Months Ended
	Mar. 31, 2021
Other Liabilities Disclosure [Abstract]
Schedule of Accrued Expenses and Other Liabilities	Accrued expenses and other liabilities consisted of the following (in thousands): March 31, December 31, 2021 2020 Accrued compensation costs $ 569 $ 411 Accrued professional fees 255 236 Accrued taxes and regulatory fees 156 137 Customer deposits 136 127 Other accrued expenses and liabilities 417 286 Accrued dividends on Series A-2 Preferred Stock — 4 Accrued expenses and other liabilities $ 1,533 $ 1,201

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
Schedule of Long-term Debt	Debt consisted of the following (in thousands): March 31, December 31, 2021 2020 PPP Loan Principal $ 2,417 $ 2,417 Less: current maturities 2,417 2,014 Long-term obligations, net of current maturities $ — $ 403

Capital Stock (Tables)

Capital Stock (Tables)	3 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Schedule of Warrants Activity	Warrant activity for the year ended December 31, 2020 is presented below. There was no warrant activity for the three months ended March 31, 2021. Outstanding Number of Warrants (in thousands) Weighted Average Exercise Price Warrants outstanding and exercisable, December 31, 2019 72 0.01 Granted 1,147 4.85 Exercised (72) 0.01 Warrants outstanding and exercisable, December 31, 2020 1,147 $ 4.85 Warrants outstanding and exercisable, March 31, 2021 1,147 $ 4.85
Summary of Treasury Stock Activity	The following table shows the activity for Treasury Stock during the year ended December 31, 2020 (in thousands). There were no treasury stock transactions during the three months ended March 31, 2021. Shares Value Treasury Shares as of December 31, 2019 105 $ (165) Purchases to cover stock compensation taxes 8 $ (16) Treasury Shares as of December 31, 2020 113 $ (181) Treasury Shares as of March 31, 2021 113 $ (181)

Stock Based Compensation (Table

Stock Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2021
Share-based Payment Arrangement [Abstract]
Summary of Options Granted, Exercised, Expired and Forfeited	A summary of stock options expired and forfeited under our plans and options outstanding as of, and changes made during, the three months ended March 31, 2021 and the year ended December 31, 2020 is presented below: Outstanding and Exercisable Number of Options Weighted Average Exercise Price Options outstanding and exercisable, December 31, 2019 215,345 $ 12.27 Expired (107,845) 4.92 Forfeited — — Options outstanding and exercisable, December 31, 2020 107,500 19.64 Options outstanding and exercisable, March 31, 2021 107,500 $ 19.64
Shares Outstanding and Exercisable, By Exercise Price Range	Additional information as of March 31, 2021 is as follows: Outstanding and Exercisable Range of price Number Weighted Weighted $0.00 – $10.00 2,500 2.20 $ 9.00 $10.01 – $20.00 97,500 1.81 19.32 $20.01 – $30.00 2,500 1.19 21.80 $30.01 – $40.00 5,000 0.96 30.20 107,500 1.76 $ 19.64
Schedule of Compensation Expense	Stock-based compensation expense relating to Restricted Series D Preferred Stock is allocated as follows (in thousands): Three Months Ended March 31, 2021 2020 Research and development $ 17 $ 47 Sales, general and administrative $ 16 $ 111 $ 33 $ 158

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2021
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data): Three Months Ended March 31, 2021 2020 Numerator: Net loss $ (3,433) $ (3,129) Less: preferred stock dividends (1) (4) Less: undeclared dividends (366) — Less: loss on induced conversion of Series A-2 Preferred Stock (300) — Net loss attributable to common stockholders $ (4,100) $ (3,133) Denominator: Weighted-average number of shares of common stock for diluted net loss per share 17,756 5,204 Basic and diluted net loss per share $ (0.23) $ (0.60)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss): Three Months Ended March 31, 2021 2020 Unvested restricted stock units — 23,334 Outstanding stock options 107,500 215,345 Unvested restricted stock awards 627 627 Shares of common stock issuable upon conversion of Series A-2 preferred stock — 10,978 Shares of common stock issuable upon conversion of Series C preferred stock — 108,333 Shares of common stock issuable upon conversion of Series D preferred stock — 17,020,460 Shares of common stock issuable upon conversion of Series E preferred stock — 1,315,790 Warrants 1,146,500 72,394

Segment Reporting (Tables)

Segment Reporting (Tables)	3 Months Ended
	Mar. 31, 2021
Segment Reporting [Abstract]
Schedule of Segment Reporting Information	Certain information concerning the Company’s segments for the three months ended March 31, 2021 is presented in the following tables (in thousands): Three Months Ended March 31, 2021 Oblong (formerly Glowpoint) Oblong Industries Corporate Total Revenue $ 1,195 $ 723 $ — $ 1,918 Cost of revenues 833 457 — 1,290 Gross profit $ 362 $ 266 $ — $ 628 Gross profit % 30 % 37 % 33 % Allocated operating expenses $ 110 $ 1,831 $ — $ 1,941 Unallocated operating expenses $ — $ — 2,098 2,098 Total operating expenses $ 110 $ 1,831 $ 2,098 $ 4,039 Income (loss) from operations $ 252 $ (1,565) $ (2,098) $ (3,411) Interest and other expense, net 5 17 $ — 22 Net income (loss) before tax $ 247 $ (1,582) $ (2,098) $ (3,433) Income Tax $ — $ — $ — $ — Net income (loss) $ 247 $ (1,582) $ (2,098) $ (3,433) Three Months Ended March 31, 2020 Oblong (formerly Glowpoint) Oblong Industries Corporate Total Revenue $ 2,045 $ 3,283 $ — $ 5,328 Cost of revenues 1,156 1,218 — 2,374 Gross profit $ 889 $ 2,065 $ — $ 2,954 Gross profit % 43 % 63 % 55 % Allocated operating expenses $ 1,290 $ 2,073 $ — $ 3,363 Unallocated operating expenses — — 2,568 2,568 Total operating expenses $ 1,290 $ 2,073 $ 2,568 $ 5,931 Loss from operations $ (401) $ (8) $ (2,568) $ (2,977) Interest and other expense, net — — 152 152 Loss before income taxes $ (401) $ (8) $ (2,720) $ (3,129) Income tax expense $ — $ — $ — $ — Net loss $ (401) $ (8) $ (2,720) $ (3,129) Concentration of revenues was as follows: Three Months Ended March 31, 2021 2020 Segment % of Revenue % of Revenue Customer A Oblong (formerly Glowpoint) 36 % 11 % Customer B Oblong Industries — % 22 % Customer C Oblong (formerly Glowpoint) 10 % * Concentration of accounts receivable was as follows: As of March 31, 2021 2021 2020 Segment % of Accounts Receivable % of Accounts Receivable Customer A Oblong Industries 36 % — % Customer B Oblong (formerly Glowpoint) 14 % * Customer C Oblong Industries — % 42 % Customer D Oblong Industries * 11 % * The amount did not exceed 10% of the Company’s consolidated total accounts receivable.
Revenue from External Customers by Geographic Areas	Revenue by geographic area is allocated as follows (in thousands): Three Months Ended March 31, 2021 2020 Domestic $ 1,015 $ 3,602 Foreign 903 1,726 $ 1,918 $ 5,328
Schedule of Disaggregated Revenue Information	Disaggregated information for the Company’s revenue has been recognized in the accompanying condensed consolidated statements of operations and is presented below according to contract type (in thousands): Three Months Ended March 31, 2021 % of Revenue 2020 % of Revenue Revenue: Oblong (formerly Glowpoint) Video collaboration services $ 291 15 % $ 1,046 20 % Network services 881 46 % 925 17 % Professional and other services 23 1 % 74 1 % Total Oblong revenue $ 1,195 62 % $ 2,045 38 % Revenue: Oblong Industries Visual collaboration product offerings $ 693 36 % 2,322 44 % Professional services — — % 669 13 % Licensing 30 2 % 292 5 % Total Oblong Industries revenue $ 723 38 % 3,283 62 % Total revenue $ 1,918 100 % $ 5,328 100 %

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Balance Sheet Information	The following provides balance sheet information related to leases as of March 31, 2021 (in thousands): March 31, 2021 Assets Operating lease, right-of-use asset, net $ 773 Liabilities Current portion of operating lease liabilities $ 797 Operating lease liabilities, net of current portion 423 Total operating lease liabilities $ 1,220
Schedule of Future Minimum Rental Payments for Operating Leases	The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands): Remaining Lease Payments Remainder of 2021 $ 661 2022 508 2023 116 Total lease payments $ 1,285 Effect of discounting (65) Total lease liability $ 1,220

Business Description and Sign_3

Business Description and Significant Accounting Policies (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2021USD ($)segment	Mar. 31, 2020USD ($)
Accounting Policies [Abstract]
Number of operating segments | segment	2
Property, Plant and Equipment [Line Items]
Impairment charges - property and equipment | $	$ 31	$ 0
Minimum
Property, Plant and Equipment [Line Items]
Useful lives	3 years
Maximum
Property, Plant and Equipment [Line Items]
Useful lives	10 years

Liquidity and Going Concern U_2

Liquidity and Going Concern Uncertainty (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Apr. 10, 2020
Line of Credit Facility [Line Items]
Cash	$ 3,964	$ 2,059	$ 5,058
Working capital	1,689
Net loss	3,433	3,129
Net cash used in operating activities	1,235	$ 2,536
PPP Loan
Line of Credit Facility [Line Items]
Long term debt	$ 2,417		$ 2,417	$ 2,417

Goodwill - Narrative (Details)

Goodwill - Narrative (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2021USD ($)segment	Mar. 31, 2020USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Goodwill [Line Items]
Goodwill	$ 7,367,000		$ 7,367,000	$ 7,908,000
Number of reporting units | segment	2
Impairment charges - goodwill	$ 0	$ 541,000	541,000
Oblong Industries
Goodwill [Line Items]
Goodwill	7,367,000		7,367,000	7,367,000
Impairment charges - goodwill	0		0
Oblong (formerly Glowpoint)
Goodwill [Line Items]
Goodwill	$ 0		0	$ 541,000
Impairment charges - goodwill		$ 541,000	$ 541,000

Goodwill - Schedule of Goodwill

Goodwill - Schedule of Goodwill (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Goodwill [Roll Forward]
Beginning balance	$ 7,367,000	$ 7,908,000	$ 7,908,000
Impairment charges	0	(541,000)	(541,000)
Ending balance	7,367,000		7,367,000
Oblong (formerly Glowpoint)
Goodwill [Roll Forward]
Beginning balance	0	541,000	541,000
Impairment charges		(541,000)	(541,000)
Ending balance	0		0
Oblong Industries
Goodwill [Roll Forward]
Beginning balance	7,367,000	$ 7,367,000	7,367,000
Impairment charges	0		0
Ending balance	$ 7,367,000		$ 7,367,000

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Gross Carrying Amount	$ 13,774	$ 13,774
Accumulated Amortization	(4,231)	(3,634)
Net Carrying Amount	9,543	10,140
Oblong (formerly Glowpoint) | Affiliate network
Business Acquisition [Line Items]
Gross Carrying Amount	994	994
Accumulated Amortization	(752)	(735)
Net Carrying Amount	$ 242	259
Estimated Useful Life	12 years
Oblong Industries
Business Acquisition [Line Items]
Gross Carrying Amount	$ 12,780	12,780
Accumulated Amortization	(3,479)	(2,899)
Net Carrying Amount	9,301	9,881
Oblong Industries | Developed technology
Business Acquisition [Line Items]
Gross Carrying Amount	10,060	10,060
Accumulated Amortization	(3,024)	(2,520)
Net Carrying Amount	$ 7,036	7,540
Estimated Useful Life	5 years
Oblong Industries | Trade names
Business Acquisition [Line Items]
Gross Carrying Amount	$ 2,410	2,410
Accumulated Amortization	(362)	(302)
Net Carrying Amount	$ 2,048	2,108
Estimated Useful Life	10 years
Oblong Industries | Distributor relationships
Business Acquisition [Line Items]
Gross Carrying Amount	$ 310	310
Accumulated Amortization	(93)	(77)
Net Carrying Amount	$ 217	$ 233
Estimated Useful Life	5 years

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Business Acquisition [Line Items]
Amortization expense	$ 597	$ 611
Minimum
Business Acquisition [Line Items]
Intangible assets, estimated useful life	5 years
Maximum
Business Acquisition [Line Items]
Intangible assets, estimated useful life	12 years

Intangible Assets - Schedule _2

Intangible Assets - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2021	$ 1,791
2022	2,386
2023	2,378
2024	1,843
2025	241
Thereafter	904
Net Carrying Amount	$ 9,543	$ 10,140

Accrued Expenses and Other Li_3

Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Other Liabilities Disclosure [Abstract]
Accrued compensation costs	$ 569	$ 411
Accrued professional fees	255	236
Accrued taxes and regulatory fees	156	137
Customer deposits	136	127
Other accrued expenses and liabilities	417	286
Accrued dividends on Series A-2 Preferred Stock	0	4
Accrued expenses and other liabilities	$ 1,533	$ 1,201

Debt - Schedule of Long-term De

Debt - Schedule of Long-term Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020	Apr. 10, 2020
Debt Instrument [Line Items]
Current portion of long-term debt	$ 2,417	$ 2,014
PPP Loan
Debt Instrument [Line Items]
Long term debt	2,417	2,417	$ 2,417
Current portion of long-term debt	2,417	2,014
Long-term obligations, net of current maturities	$ 0	$ 403

Debt - Paycheck Protection Prog

Debt - Paycheck Protection Program Loan (Details) - PPP Loan $ in Thousands	Mar. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Apr. 10, 2020USD ($)installment
Debt Instrument [Line Items]
Long term debt	$ 2,417	$ 2,417	$ 2,417
Fixed rate			1.00%
Number of monthly installments | installment			18
Interest accrued	$ 22

Capital Stock - Common Stock (D

Capital Stock - Common Stock (Details) - $ / shares	Mar. 31, 2021	Dec. 31, 2020
Equity [Abstract]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	26,729,331	7,861,912
Common stock, shares outstanding (in shares)	26,616,048	7,748,629

Capital Stock - Additional Info

Capital Stock - Additional Information (Details) - USD ($)	Jan. 21, 2021	Dec. 10, 2020	Dec. 06, 2020	Oct. 21, 2020	Oct. 01, 2019	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Class of Stock [Line Items]
Conversion of convertible preferred stock, shares (in shares)					1,315,790
Issuance of stock for services						$ 274,000
Issuance of common shares from warrant exercise (in shares)				521,500
Warrant term				2 years
Exercise price (in dollars per share)						$ 4.85		$ 4.85	$ 0.01
Warrant exercises						0
General and administrative expense
Class of Stock [Line Items]
Accrued professional fees						$ 274,000
Warrants
Class of Stock [Line Items]
Issuance of common shares from warrant exercise (in shares)			625,000
Warrant term			2 years
Exercise price (in dollars per share)			$ 5.49	$ 4.08
Fair value of SVB Warrant			$ 2,635,425	$ 1,334,087
Common Stock
Class of Stock [Line Items]
Conversion of convertible preferred stock, shares (in shares)						18,846,411	50,000
Issuance of shares for professional service fees (in shares)	21,008	50,000				21,008
Issuance of stock for services	$ 100,000	$ 348,000

Capital Stock - Warrants Activi

Capital Stock - Warrants Activity (Details) - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2020	Mar. 31, 2021
Number of Warrants (in thousands)
Warrants outstanding and exercisable, Beginning (in shares)	72
Granted (in shares)	1,147
Exercised (in shares)	(72)
Warrants outstanding and exercisable, Ending (in shares)	1,147
Warrants outstanding and exercisable, Ending (in shares)	1,147	1,147
Weighted Average Exercise Price
Warrants outstanding and exercisable, Beginning (in dollars per share)	$ 0.01
Granted, (in dollars per share)	4.85
Exercised, (in dollars per share)	0.01
Warrants outstanding and exercisable, Ending (in dollars per share)	4.85
Warrants outstanding and exercisable, Ending (in dollars per share)	$ 4.85	$ 4.85

Capital Stock - Equity Activity

Capital Stock - Equity Activity (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	$ 22,057	$ 21,785	$ 21,785
Purchases to cover stock compensation taxes	33	32
Ending Balance	18,931	18,775	22,057
Ending Balance	$ 22,057	$ 18,775	$ 21,785
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)	113,283	105,285	105,285
Beginning Balance	$ (181)	$ (165)	$ (165)
Purchases to cover stock compensation taxes (in shares)			8,000
Purchases to cover stock compensation taxes			$ (16)
Ending Balance (in shares)	113,283	105,285	113,283
Ending Balance	$ (181)	$ (172)	$ (181)
Ending Balance	$ (181)	$ (165)	$ (181)

Preferred Stock (Details)

Preferred Stock (Details) - USD ($)	Jan. 28, 2021	Oct. 01, 2019	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)			5,000,000
Preferred stock designated share			1,941,250
Preferred stock, shares issued (in shares)			0
Preferred stock, shares outstanding (in shares)			0		1,829,582
Accrued dividends on Series A-2 Preferred Stock			$ 0		$ 4,000
Dividends			$ 1,000
Preferred stock conversion	$ 300,000
Conversion of convertible preferred stock, shares (in shares)		1,315,790
Common Stock
Class of Stock [Line Items]
Shares issued in conversion (in shares)	84,292				20,954
Conversion of convertible preferred stock, shares (in shares)			18,846,411	50,000
Restricted stock
Class of Stock [Line Items]
Vesting period			10 years
Series A-2 Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)			7,500		7,500
Preferred stock, shares issued (in shares)			0		45
Preferred stock, shares outstanding (in shares)	45		0		45
Preferred stock, stated value			$ 7,500		$ 7,500
Stock issued during period, conversion of convertible securities, price (in dollars per share)	$ 4				$ 16.11
Preferred stock percentage					5.00%
Series A-2 Preferred Stock | Preferred Stock
Class of Stock [Line Items]
Conversion of convertible preferred stock, shares (in shares)			(45)
Series A-2 Preferred Stock | Common Stock
Class of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)					466
Conversion of convertible preferred stock, shares (in shares)			84,292
Series D Convertible Preferred Stock | Common Stock
Class of Stock [Line Items]
Preferred stock, shares outstanding (in shares)		17,416,939
Series D Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)			1,750,000		1,750,000
Preferred stock, shares issued (in shares)			0		1,697,958
Preferred stock, shares outstanding (in shares)			0		1,697,958
Preferred stock, stated value			$ 28.50		$ 28.50
Shares issued in conversion (in shares)		1,697,022
Preferred stock percentage		6.00%
Conversion of convertible preferred stock, shares (in shares)		1,686,659
Forfeited, restricted shares (in shares)			81		28,618
Series D Preferred Stock | Preferred Stock
Class of Stock [Line Items]
Preferred stock, shares issued (in shares)			855		8,325
Conversion of convertible preferred stock, shares (in shares)			(1,697,022)
Series D Preferred Stock | Restricted stock
Class of Stock [Line Items]
Issuance of restricted stock (in shares)		49,967
Vesting period		2 years
Forfeited, restricted shares (in shares)			81	14,441
Series E Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)			175,000		175,000
Preferred stock, shares issued (in shares)			0		131,579
Preferred stock, shares outstanding (in shares)		131,579	0		131,579
Preferred stock, stated value		$ 28.50	$ 28.50		$ 28.50
Shares issued in conversion (in shares)		131,579
Preferred stock percentage			6.00%
Series E Preferred Stock | Preferred Stock
Class of Stock [Line Items]
Conversion of convertible preferred stock, shares (in shares)			(131,579)
Series E Preferred Stock | Common Stock
Class of Stock [Line Items]
Preferred stock, shares outstanding (in shares)		1,345,180
Series E Preferred Stock | Series E Financing
Class of Stock [Line Items]
Preferred stock, shares issued (in shares)		131,579
Stock issued during period, conversion of convertible securities, price (in dollars per share)		$ 2.85
Sale of stock consideration received		$ 3,750,000	$ 3,750,000
Sale of stock, price per share (in dollars per share)		$ 2.85

Stock Based Compensation - Narr

Stock Based Compensation - Narrative (Details) - USD ($)	Oct. 01, 2019	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options outstanding (in shares)		107,500		107,500	215,345
Options, intrinsic value, vested		$ 0
Stock option compensation expense		0	$ 0
Unrecognized stock-based compensation expense for stock options		$ 0
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted (in shares)		0		0
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares outstanding (in shares)		627	627
Weighted average price of shares (in dollars per share)		$ 15.80	$ 15.80
Vesting period		10 years
Award service period		5 years
Unrecognized stock-based compensation expense for other than options		$ 0	$ 0
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares outstanding (in shares)		0	23,334
Stock option compensation expense		$ 0	$ 6,000
Weighted average price of shares (in dollars per share)			$ 2.20
Unrecognized stock-based compensation expense for other than options		$ 0
Stock-based compensation arrangement, vested in period, remain outstanding (in shares)		28,904
Series D Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Forfeited, restricted shares (in shares)		81		28,618
Series D Preferred Stock | Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares outstanding (in shares)		0
Stock option compensation expense		$ 33,000	$ 158,000
Vesting period	2 years
Unrecognized stock-based compensation expense for other than options		$ 0
Forfeited, restricted shares (in shares)		81	14,441

Stock Based Compensation - Opti

Stock Based Compensation - Options Outstanding (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Number of Options
Outstanding Number of Options, Beginning (in shares)	107,500	215,345
Expired (in shares)		(107,845)
Forfeited (in shares)		0
Outstanding and Exercisable Number of Options, Ending (in shares)	107,500	107,500
Weighted Average Exercise Price
Outstanding Weighted Average Exercise Price, Beginning (in dollars per share)	$ 19.64	$ 12.27
Outstanding Weighted Average Exercise Price, Expired (in dollars per share)		4.92
Outstanding Weighted Average Exercise Price, Forfeited (in dollars per share)		0
Outstanding and Exercisable Weighted Average Exercise Price, Ending (in dollars per share)	$ 19.64	$ 19.64
Exercisable
Exercisable Number of Options (in shares)	107,500	107,500	215,345
Exercisable Weighted Average Exercise Price (in dollars per share)	$ 19.64	$ 19.64	$ 12.27

Stock Based Compensation - Exer

Stock Based Compensation - Exercise Price Range (Details) - $ / shares	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of Options, Outstanding and Exercisable (in shares)	107,500	107,500	215,345
Weighted Average Remaining Contractual Life (In Years)	1 year 9 months 3 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 19.64	$ 19.64	$ 12.27
$0.00 – $10.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	0
Range of price, upper range limit (in dollars per share)	$ 10
Number of Options, Outstanding and Exercisable (in shares)	2,500
Weighted Average Remaining Contractual Life (In Years)	2 years 2 months 12 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 9
$10.01 – $20.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	10.01
Range of price, upper range limit (in dollars per share)	$ 20
Number of Options, Outstanding and Exercisable (in shares)	97,500
Weighted Average Remaining Contractual Life (In Years)	1 year 9 months 21 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 19.32
$20.01 – $30.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	20.01
Range of price, upper range limit (in dollars per share)	$ 30
Number of Options, Outstanding and Exercisable (in shares)	2,500
Weighted Average Remaining Contractual Life (In Years)	1 year 2 months 8 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 21.80
$30.01 – $40.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	30.01
Range of price, upper range limit (in dollars per share)	$ 40
Number of Options, Outstanding and Exercisable (in shares)	5,000
Weighted Average Remaining Contractual Life (In Years)	11 months 15 days
Weighted Average Exercise Price, Outstanding and Exercisable (in dollars per share)	$ 30.20

Stock Based Compensation - Stoc

Stock Based Compensation - Stock Compensation Expense, Restricted Stock Units (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	$ 0	$ 0
Series D Preferred Stock | Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	33,000	158,000
Series D Preferred Stock | Restricted stock | Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	17,000	47,000
Series D Preferred Stock | Restricted stock | Sales, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock compensation expense	$ 16,000	$ 111,000

Net Loss Per Share - Narrative

Net Loss Per Share - Narrative (Details)	3 Months Ended
	Mar. 31, 2021shares
Earnings Per Share [Abstract]
Weighted-average shares common stock outstanding, potentially dilutive securities or unvested restricted stock (in shares)	0

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Numerator:
Net loss	$ (3,433)	$ (3,129)
Less: preferred stock dividends	(1)	(4)
Less: undeclared dividends	(366)	0
Induced conversion of Series A-2 Preferred Stock	(300)	0
Net loss attributable to common stockholders	$ (4,100)	$ (3,133)
Denominator:
Weighted-average number of shares of common stock for diluted net loss per share (in shares)	17,756	5,204
Basic and diluted net loss per share (in dollars per share)	$ (0.23)	$ (0.60)

Net Loss Per Share - Effect of

Net Loss Per Share - Effect of Antidilutive Securities (Details) - shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Unvested restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	23,334
Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	107,500	215,345
Unvested restricted stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	627	627
Series A-2 Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	10,978
Series C Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	108,333
Series D Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	17,020,460
Series E Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	1,315,790
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1,146,500	72,394

Segment Reporting (Details)

Segment Reporting (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2021USD ($)segment	Mar. 31, 2020USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | segment	2
Revenue	$ 1,918	$ 5,328
Cost of revenues	1,290	2,374
Gross profit	$ 628	$ 2,954
Gross profit %	33.00%	55.00%
Total operating expenses	$ 4,039	$ 5,931
Loss from operations	(3,411)	(2,977)
Interest and other expense, net	22	152
Loss before income taxes	(3,433)	(3,129)
Income tax expense	0	0
Net loss	(3,433)	(3,129)
Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	1,941	3,363
Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	2,098	2,568
Oblong (formerly Glowpoint)
Segment Reporting Information [Line Items]
Revenue	1,195	2,045
Cost of revenues	833	1,156
Gross profit	$ 362	$ 889
Gross profit %	30.00%	43.00%
Total operating expenses	$ 110	$ 1,290
Loss from operations	252	(401)
Interest and other expense, net	5	0
Loss before income taxes	247	(401)
Income tax expense	0	0
Net loss	247	(401)
Oblong (formerly Glowpoint) | Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	110	1,290
Oblong (formerly Glowpoint) | Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	0	0
Oblong Industries
Segment Reporting Information [Line Items]
Revenue	723	3,283
Cost of revenues	457	1,218
Gross profit	$ 266	$ 2,065
Gross profit %	37.00%	63.00%
Total operating expenses	$ 1,831	$ 2,073
Loss from operations	(1,565)	(8)
Interest and other expense, net	17	0
Loss before income taxes	(1,582)	(8)
Income tax expense	0	0
Net loss	(1,582)	(8)
Oblong Industries | Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	1,831	2,073
Oblong Industries | Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	0	0
Corporate
Segment Reporting Information [Line Items]
Revenue	0	0
Cost of revenues	0	0
Gross profit	0	0
Total operating expenses	2,098	2,568
Loss from operations	(2,098)	(2,568)
Interest and other expense, net	0	152
Loss before income taxes	(2,098)	(2,720)
Income tax expense	0	0
Net loss	(2,098)	(2,720)
Corporate | Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	0	0
Corporate | Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	$ 2,098	$ 2,568

Segment Reporting - Disaggregat

Segment Reporting - Disaggregation of Revenue and Total Assets (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2021USD ($)	Mar. 31, 2020USD ($)
Disaggregation of Revenue [Line Items]
Foreign revenue	0.01	0.01
Revenue	$ 1,918	$ 5,328
Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	100.00%	100.00%
Oblong (formerly Glowpoint)
Disaggregation of Revenue [Line Items]
Revenue	$ 1,195	$ 2,045
Oblong (formerly Glowpoint) | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	62.00%	38.00%
Oblong (formerly Glowpoint) | Video collaboration services
Disaggregation of Revenue [Line Items]
Revenue	$ 291	$ 1,046
Oblong (formerly Glowpoint) | Video collaboration services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	15.00%	20.00%
Oblong (formerly Glowpoint) | Network services
Disaggregation of Revenue [Line Items]
Revenue	$ 881	$ 925
Oblong (formerly Glowpoint) | Network services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	46.00%	17.00%
Oblong (formerly Glowpoint) | Professional and other services
Disaggregation of Revenue [Line Items]
Revenue	$ 23	$ 74
Oblong (formerly Glowpoint) | Professional and other services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	1.00%	1.00%
Oblong Industries
Disaggregation of Revenue [Line Items]
Revenue	$ 723	$ 3,283
Oblong Industries | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	38.00%	62.00%
Oblong Industries | Video collaboration services
Disaggregation of Revenue [Line Items]
Revenue	$ 693	$ 2,322
Oblong Industries | Video collaboration services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	36.00%	44.00%
Oblong Industries | Professional and other services
Disaggregation of Revenue [Line Items]
Revenue	$ 0	$ 669
Oblong Industries | Professional and other services | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	0.00%	13.00%
Oblong Industries | Licensing
Disaggregation of Revenue [Line Items]
Revenue	$ 30	$ 292
Oblong Industries | Licensing | Revenue
Disaggregation of Revenue [Line Items]
Percentage of revenue	2.00%	5.00%
Domestic
Disaggregation of Revenue [Line Items]
Revenue	$ 1,015	$ 3,602
Foreign
Disaggregation of Revenue [Line Items]
Revenue	$ 903	$ 1,726

Segment Reporting - Concentrati

Segment Reporting - Concentration Percentage (Details)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenue
Concentration Risk [Line Items]
Concentration risk, percentage	100.00%	100.00%
Oblong (formerly Glowpoint) | Revenue
Concentration Risk [Line Items]
Concentration risk, percentage	62.00%	38.00%
Oblong Industries | Revenue
Concentration Risk [Line Items]
Concentration risk, percentage	38.00%	62.00%
Customer A | Oblong (formerly Glowpoint) | Revenue
Concentration Risk [Line Items]
Concentration risk, percentage	36.00%	11.00%
Customer A | Oblong Industries | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage	36.00%	0.00%
Customer B | Oblong (formerly Glowpoint) | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage	14.00%
Customer B | Oblong Industries | Revenue
Concentration Risk [Line Items]
Concentration risk, percentage	0.00%	22.00%
Customer C | Oblong (formerly Glowpoint) | Revenue
Concentration Risk [Line Items]
Concentration risk, percentage	10.00%
Customer C | Oblong Industries | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage	0.00%	42.00%
Customer D | Oblong Industries | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk, percentage		11.00%

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2021USD ($)facility	Mar. 31, 2020USD ($)
Lessee, Lease, Description [Line Items]
Non-cash lease expense | $	$ 267	$ 316
Los Angeles, California
Lessee, Lease, Description [Line Items]
Number of facilities	3
Number of facilities occupied	2
Boston, Massachusetts
Lessee, Lease, Description [Line Items]
Number of facilities	1
Dallas, Texas
Lessee, Lease, Description [Line Items]
Number of facilities	1
Munich, Germany
Lessee, Lease, Description [Line Items]
Number of facilities	1
Minimum
Lessee, Lease, Description [Line Items]
Term of contract	1 year
Renewal term	12 months
Maximum
Lessee, Lease, Description [Line Items]
Term of contract	3 years
Renewal term	5 years

Commitments and Contingencies_2

Commitments and Contingencies - Balance Sheet Information (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Operating lease, right-of-use asset, net	$ 773	$ 903
Current portion of operating lease liabilities	797	830
Operating lease liabilities, net of current portion	423	$ 602
Total operating lease liabilities	$ 1,220

Commitments and Contingencies_3

Commitments and Contingencies - Table Operating Lease Future Minimum Rental Commitment (Details) $ in Thousands	Mar. 31, 2021USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of 2021	$ 661
2022	508
2023	116
Total lease payments	1,285
Effect of discounting	(65)
Total lease liability	$ 1,220